Posted inClinical Updates news Respiratory
Biologic Outcomes in Severe Asthma by Smoking Status: Insights from the SHARP European Registry
SHARP registry data reveal that biologic therapies improve clinical outcomes equally in severe asthma patients irrespective of smoking status, challenging prevailing prescribing hesitancy and advocating inclusive treatment approaches.